Q3 2025 MiMedx Group Inc Earnings Call Transcript
Key Points
- MiMedx Group Inc (MDXG) reported a record quarterly revenue of $114 million, marking a 35% year-over-year growth.
- The company achieved an adjusted gross profit margin of 88% and an adjusted EBITDA of $35 million, representing 31% of net sales.
- MiMedx Group Inc (MDXG) increased its full-year 2025 revenue growth guidance from the low teens to the mid- to high teens.
- The Surgical business grew by 26% this quarter, driven by the continued growth across the portfolio.
- The company ended Q3 with $124 million in net cash, a sequential increase of $23 million, and expects to end the year with a net cash balance of more than $150 million.
- The company faces uncertainties regarding the upcoming Medicare reimbursement reforms, which could impact future financial performance.
- GAAP general and administrative expenses increased due to incremental spend from legal and regulatory disputes, including ongoing litigation with competitors and former employees.
- The company anticipates some choppiness in early 2026 as the industry navigates changes in reimbursement rules.
- There is uncertainty regarding the final CMS rules for the Physician Fee Schedule and Outpatient Prospective Payment System, which could affect the company's business model.
- MiMedx Group Inc (MDXG) is involved in ongoing legal disputes, which could potentially impact financial resources and focus.
Good afternoon, and thank you for standing by. Welcome to the MiMedx third quarter 2025 operating and financial results conference call.
(Operator Instructions) As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Mr. Matt Notarianni, Head of Investor Relations for MiMedx. Thank you. You may now begin.
Thank you, operator, and good afternoon, everyone. Welcome to the MiMedx Third Quarter 2025 Operating and Financial Results Conference Call. With me on today's call are Chief Executive Officer, Joe Capper; and Chief Financial Officer, Doug Rice.
As part of today's webcast, we are simultaneously displaying slides that you can follow. You can access the slides from the Investor Relations website at mimedx.com.
Joe will kick us off with some opening remarks and a summary of our operating highlights as well as a discussion of our financial goals, and Doug will provide a review of our financial results for the quarter. And
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
